BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2026 3:51:53 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-01-12 02:51 |
|
Peer-Review Started |
|
2026-01-12 02:52 |
|
First Decision by Editorial Office Director |
|
2026-03-27 04:01 |
|
Return for Revision |
|
2026-03-27 04:01 |
|
Revised |
|
2026-03-27 13:00 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-05-08 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-08 08:17 |
|
Articles in Press |
|
2026-05-08 08:17 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-08-14 08:43 |
|
Publish the Manuscript Online |
|
2026-08-18 03:51 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Induction immunotherapy in hyperimmunized liver transplantation: Rebalancing immunological risk and graft protection
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jin-Wei Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jin-Wei Zhang, PhD, Principal Investigator, Professor, State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, No. 345 Lingling Road, Shanghai 200032, China. jinweizhang@sioc.ac.cn |
| Key Words |
Liver transplantation; Hyperimmunization; Donor-specific antibodies; Antibody-mediated rejection; Induction immunosuppression; Anti-T-lymphocyte globulin |
| Core Tip |
For decades, hyperimmunized liver transplant recipients have faced poorer clinical outcomes due to their heightened immunological risk profile, leaving clinicians with limited evidence-based management options. This editorial delivers a comprehensive analysis of EL-Domiaty et al’s landmark study, which provides compelling clinical evidence that a short-course induction regimen of rabbit anti-T-lymphocyte globulin plus intravenous immunoglobulin can effectively mitigate early rejection risk and align outcomes with those of non-immunized recipients. This work highlights a viable, pragmatic strategy for managing this challenging patient population and paves the way for more personalized immunosuppression in liver transplantation. |
| Publish Date |
2026-08-18 03:51 |
| Citation |
Zhang JW. Letter to the Editor: Induction immunotherapy in hyperimmunized liver transplantation: Rebalancing immunological risk and graft protection. World J Hepatol 2026; 18(8): 118687
|
| URL |
https://www.wjgnet.com/1948-5182/full/v18/i8/118687.htm |
| DOI |
https://doi.org/10.4254/wjh.118687 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
